LE
Legend Biotech
LEGN·NASDAQSomerset NJFounded 20142,800 employees
Large CapbiotechPublicOncologyHematology
Platform: CAR-T Carvykti
Market Cap
$10B
All Drugs
5
Clinical Trials
9
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (LEGN)
Loading LEGN stock data...
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Fixatuximab | LEG-9035 | Preclinical | 2 | CFTR | Parkinson'sFTD | ||
| Pemicapivasertib | LEG-2115 | Phase 3 | 3 | VEGF | HNSCC | ||
| Sematapinarof | LEG-5243 | NDA/BLA | 1 | VEGF | MDDSCD | ||
| LEG-6533 | LEG-6533 | NDA/BLA | 2 | VEGF | MigraineGA | ||
| LEG-9870 | LEG-9870 | Phase 1 | 1 | CGRP | WM |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (8)